Cyclopentolate
Dilation & diagnostic · Rx
RxDilation & diagnosticMydriatic Red cap
| Strength | 0.5%, 1%, 2% |
|---|---|
| Drug class | Intermediate-acting anticholinergic cycloplegic |
| Mechanism of action | Muscarinic antagonist with strong ciliary-muscle blockade; the standard office cycloplegic for refraction. |
| Indication / reason for use | Cycloplegic refraction (especially children and hyperopes), pediatric fundus exam, anterior uveitis (comfort + prevention of synechiae). |
| Usual adult dosing | Refraction: 1 drop of 1% (0.5% in infants; 2% for heavily pigmented irides), repeat once at 5 min; refract at 30-40 min. Cycloplegia lasts 6-24 h, mydriasis up to 24 h. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | CNS toxicity in children, disorientation, hallucinations, ataxia, slurred speech, seizures (dose-related; 2% carries the highest risk); GI: feeding intolerance / ileus in infants; photophobia and blur for a day. Angle-closure risk in narrow angles. |
| Contraindications & cautions | Untreated narrow angles; use 0.5% and punctal occlusion in infants; avoid 2% in children. |
| Pregnancy / lactation | Limited data; minimize dose, use punctal occlusion. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Cyclogyl, Cylate |
| Practice notes | In infants use the 0.5% strength, press on the puncta, and wipe excess from the lids to limit systemic absorption. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.